Celegence CEO Sonia Veluchamy Featured in PharmaTimes Magazine

Our CEO Sonia A. Veluchamy shares valuable perspectives in the September 2024 issue of PharmaTimes Magazine on optimizing regulatory strategies for medical device companies by adopting successful pharmaceutical industry practices.

• Resource challenges are cited based on recent research conducted by Celegence and industry partners to reveal 77% of regulatory departments in medical device teams are under-resourced
• The article explores how implementing advanced content management systems and automation can revolutionize regulatory operations for medical device manufacturers together with expertise
• Insights on the future of regulatory technology, including the strategic implementation of AI solutions to enhance compliance processes and operational efficiency

Read the full article in PharmaTimes Magazine.

Celegence has proven experience with medical writing for regulatory submissions. Our deep regulatory expertise, combined with advanced AI-Enabled technology solutions, positions us uniquely to handle the complexities of medical writing. We ensure that every document is not only compliant but crafted to expedite approval processes and facilitate market access. For more information about our services can benefit your regulatory processes, contact us today.